Timely initiation of ART (before profound CD4+ T-cell depletion occurs) could at least in part prevent irreversible immune dysfunction, and reducing persistent immune activation might possibly limit the occurrence of non-AIDS clinical events in HIV-infected people [13–15]. The gene discussed is CD4; the disease is AIDS.